Premium
Loperamide and P‐glycoprotein modulator in opioid detoxification
Author(s) -
Al Garhy Mohamed,
Mohan Sona,
Al Dhufairi Aisha
Publication year - 2021
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.717
Subject(s) - loperamide , detoxification (alternative medicine) , opiate , omeprazole , opioid , medicine , pharmacology , receptor , diarrhea , alternative medicine , pathology
Opioids contribute to 70% of the negative health impact associated with drug use disorders. A new opioid withdrawal protocol using over‐the‐counter medications loperamide and P‐glycoprotein inhibitor (omeprazole) was described by Dr Al Garhy previously. In this article the successful use of this protocol, evidenced by the Clinical Opiate Withdrawal Scale, is discussed in a case series.